Literature DB >> 34283876

COVID-19 cumulative incidence, asymptomatic infections, and fatality in Long Island, NY, January-August 2020: A cohort of World Trade Center responders.

Olga Morozova1,2, Sean A P Clouston1,2, Jennifer Valentine3, Alexander Newman3, Melissa Carr3, Benjamin J Luft3,4.   

Abstract

BACKGROUND: New York City and Long Island, NY were early foci of the COVID-19 epidemic in the US. The effects of COVID-19 on different sub-populations, and its key epidemiologic parameters remain unknown or highly uncertain. We investigated the epidemiology of COVID-19 from January to August of 2020 in an established academic monitoring cohort of N = 9,697 middle-aged World Trade Center responders residing in Long Island, NY.
METHODS: A seroprevalence survey and a series of cross-sectional surveys were nested in a prospective cohort study. Measures included IgG antibody testing, SARS-CoV-2 polymerase chain reaction (PCR) testing, review of electronic medical records, and surveys of symptoms. Correlates of infection were analyzed with multivariable logistic regression.
RESULTS: The cohort was predominantly men in their mid-fifties; 6,597 cohort members were successfully contacted (68%); 1,042 (11%) individuals participated in the seroprevalence survey; and 369 individuals (5.6% of 6,597 study participants) underwent PCR testing. The estimated standardized cumulative incidence was 21.9% (95%CI: 20.1-23.9%), the asymptomatic proportion was 16.4% (36/219; 95%CI: 11.8-22.0%), the case hospitalization ratio was 9.4% (36/385; 95%CI: 6.6-12.7%), the case fatality ratio was 1.8% (7/385; 95%CI: 0.7-3.7%), and the hospitalization fatality ratio was 8.3% (3/36; 95%CI: 1.8-22.5%). Confirmed SARS-CoV-2 infection was associated with younger age, race/ethnicity, and being currently employed.
CONCLUSIONS: The results of the present study suggest a high cumulative incidence of SARS-CoV-2 among WTC responders in the spring and summer of 2020 and contribute to narrowing the plausible range of the proportion of infections that exhibit no symptoms. An increased risk of infection among younger employed individuals is likely to reflect a higher probability of exposure to the virus, and the racial disparities in the infection risk warrant further investigation.

Entities:  

Year:  2021        PMID: 34283876     DOI: 10.1371/journal.pone.0254713

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

1.  Covid-19 antibody tests: a briefing.

Authors:  Chris Baraniuk
Journal:  BMJ       Date:  2020-06-24

2.  Determinants of COVID-19 disease severity in patients with cancer.

Authors:  Ying Taur; Mini Kamboj; Elizabeth V Robilotti; N Esther Babady; Peter A Mead; Thierry Rolling; Rocio Perez-Johnston; Marilia Bernardes; Yael Bogler; Mario Caldararo; Cesar J Figueroa; Michael S Glickman; Alexa Joanow; Anna Kaltsas; Yeon Joo Lee; Anabella Lucca; Amanda Mariano; Sejal Morjaria; Tamara Nawar; Genovefa A Papanicolaou; Jacqueline Predmore; Gil Redelman-Sidi; Elizabeth Schmidt; Susan K Seo; Kent Sepkowitz; Monika K Shah; Jedd D Wolchok; Tobias M Hohl
Journal:  Nat Med       Date:  2020-06-24       Impact factor: 53.440

3.  Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001.

Authors:  Sean A P Clouston; Erica D Diminich; Roman Kotov; Robert H Pietrzak; Marcus Richards; Avron Spiro; Yael Deri; Melissa Carr; Xiaohua Yang; Sam Gandy; Mary Sano; Evelyn J Bromet; Benjamin J Luft
Journal:  Alzheimers Dement (Amst)       Date:  2019-09-06

4.  Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.

Authors:  Eli S Rosenberg; James M Tesoriero; Elizabeth M Rosenthal; Rakkoo Chung; Meredith A Barranco; Linda M Styer; Monica M Parker; Shu-Yin John Leung; Johanne E Morne; Danielle Greene; David R Holtgrave; Dina Hoefer; Jessica Kumar; Tomoko Udo; Brad Hutton; Howard A Zucker
Journal:  Ann Epidemiol       Date:  2020-06-17       Impact factor: 3.797

5.  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.

Authors:  Andrew T Levin; William P Hanage; Nana Owusu-Boaitey; Kensington B Cochran; Seamus P Walsh; Gideon Meyerowitz-Katz
Journal:  Eur J Epidemiol       Date:  2020-12-08       Impact factor: 8.082

6.  SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020.

Authors:  Daniel C Payne; Sarah E Smith-Jeffcoat; Gosia Nowak; Uzo Chukwuma; Jesse R Geibe; Robert J Hawkins; Jeffrey A Johnson; Natalie J Thornburg; Jarad Schiffer; Zachary Weiner; Bettina Bankamp; Michael D Bowen; Adam MacNeil; Monita R Patel; Eric Deussing; Bruce L Gillingham
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-12       Impact factor: 17.586

7.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

8.  SARS-CoV-2 (COVID-19) by the numbers.

Authors:  Yinon M Bar-On; Avi Flamholz; Rob Phillips; Ron Milo
Journal:  Elife       Date:  2020-04-02       Impact factor: 8.140

9.  COVID-19 antibody seroprevalence in Santa Clara County, California.

Authors:  Eran Bendavid; Bianca Mulaney; Neeraj Sood; Soleil Shah; Rebecca Bromley-Dulfano; Cara Lai; Zoe Weissberg; Rodrigo Saavedra-Walker; Jim Tedrow; Andrew Bogan; Thomas Kupiec; Daniel Eichner; Ribhav Gupta; John P A Ioannidis; Jay Bhattacharya
Journal:  Int J Epidemiol       Date:  2021-05-17       Impact factor: 7.196

10.  Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.

Authors:  Shuchi Anand; Maria Montez-Rath; Jialin Han; Julie Bozeman; Russell Kerschmann; Paul Beyer; Julie Parsonnet; Glenn M Chertow
Journal:  Lancet       Date:  2020-09-25       Impact factor: 202.731

View more
  3 in total

1.  Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.

Authors:  Ilya Kister; Yury Patskovsky; Ryan Curtin; Jinglan Pei; Katherine Perdomo; Zoe Rimler; Iryna Voloshyna; Marie I Samanovic; Amber R Cornelius; Yogambigai Velmurugu; Samantha Nyovanie; Joseph J Kim; Ethan Tardio; Tamar E Bacon; Lana Zhovtis Ryerson; Pranil Raut; Rosetta Pedotti; Kathleen Hawker; Catarina Raposo; Jessica Priest; Mark Cabatingan; Ryan C Winger; Mark J Mulligan; Michelle Krogsgaard; Gregg J Silverman
Journal:  Ann Neurol       Date:  2022-04-01       Impact factor: 11.274

2.  The Impact of World Trade Center Related Medical Conditions on the Severity of COVID-19 Disease and Its Long-Term Sequelae.

Authors:  Elizabeth Lhuillier; Yuan Yang; Olga Morozova; Sean A P Clouston; Xiaohua Yang; Monika A Waszczuk; Melissa A Carr; Benjamin J Luft
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

3.  Risk Factors for COVID-19 in a Retired FDNY WTC-Exposed Cohort.

Authors:  Krystal L Cleven; Rachel Zeig-Owens; David G Goldfarb; Theresa Schwartz; David J Prezant
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.